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Dysfunction of T helper 17 (Th17) cells leads to chronic inflammatory disorders. Signal
transducer and activator of transcription 3 (STAT3) orchestrates the expression of
proinflammatory cytokines and pathogenic cell differentiation from interleukin (IL)-17producing Th17 cells. However, the pathways mediated by STAT3 signaling are not fully
understood. Here, we observed that Fos-related antigen 1 (FRA1) and JUNB are directly
involved in STAT3 binding to sites in the promoters of Fosl1 and Junb. Promoter binding
increased expression of IL-17 and the development of Th17 cells. Overexpression of Fra1
and Junb in mice resulted in susceptibility to collagen-induced arthritis and an increase
in Th17 cell numbers and inflammatory cytokine production. In patients with rheumatoid
arthritis, FRA1 and JUNB were colocalized with STAT3 in the inflamed synovium. These
observations suggest that FRA1 and JUNB are associated closely with STAT3 activation,
and that this activation leads to Th17 cell differentiation in autoimmune diseases and
inflammation.
Keywords: Fos-related antigen 1-JUNB, signal transducer and activator of transcription 3, T helper 17, autoimmune
arthritis, inflammation
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INTRODUCTION

To generate Fra1/Junb Tg mice, a pcDNA3.1+HA (Invitrogen,
CA, USA) vector containing the FRA1 and JUNB proteins
coupled to a linker peptide (3 × GGGGS) was constructed. The
Fra1/Junb fragment was synthesized by GenScript Corporation
(NJ, USA), with codon optimization for expression in mammalian cells. Fra1/Junb Tg mice were bred from the C57BL/6 line
and maintained in facilities at Macrogen Laboratories (Seoul,
Korea). All mice were maintained under specific-pathogen-free
conditions at the Institute of Medical Science, The Catholic
University of Korea. The presence of the transgene in the founders was confirmed by PCR of genomic DNA extracted from
the tail samples. Genotyping was performed by PCR analysis
of genomic DNA obtained from mice at 3 weeks of age. All
experimental procedures were examined and approved by the
Animal Research Ethics Committee at the Catholic University
of Korea.

T helper 17 (Th17) cells are a pathogenic subset of T helper
lymphocytes that play a key role in inflammatory disorders
leading to a severe chronic immune inflammatory response.
Th17 cells release several proinflammatory cytokines including
interleukin (IL)-17A, IL-21, and IL-22 (1). IL-17A is an inflammatory cytokine produced predominantly by Th17 cells with
strong effects on stromal cells. IL-17A induces inflammatory
cytokine production and leukocyte recruitment, which act to link
the innate and adaptive branches of immunity (2). Both IL-17A
and Th17 cells are highly involved in the pathogenesis of several
autoimmune diseases, including rheumatoid arthritis (RA) (3, 4),
while playing a significant role in autoimmune disorders mediated by excessive inflammation.
Signal transducer and activator of transcription 3 (STAT3) is
an important transcription factor with DNA-binding properties
whose activity is paramount to the inflammatory response. It has
been suggested that STAT3 activation upregulates IL-17 production via Th17 cell proliferation (5, 6). Several transcription factors
including STAT3 regulate Th17 cell differentiation (7–12); however, STAT3 also plays a key role in the immune inflammatory
response. There is a general consensus that STAT3 is essential for
Th17 cell differentiation (13). Moreover, STAT3 modulates the
production of several cytokines including IL-17A and activates
downstream transcription factors, such as RAR-related orphan
receptor gamma isoform 2 (RORγt), which is responsible for the
Th17 phenotype (14, 15).
The activator protein 1 (AP-1) family is a group of structurally
and functionally related JUN (c-JUN, JUNB, and JUND) and
FOS [c-FOS, FOSB, Fos-related antigen 1 (FRA1), and FRA2]
transcription factors. AP-1 heterodimers are involved in a variety
of biological processes including cell proliferation, differentiation, apoptosis, and inflammation (16, 17). It has been suggested
that AP-1 proteins are involved in several pathological conditions
(18–21), while JUN and FOS proteins are also associated with
the immune inflammatory response. Modulation of c-FOS and
c-JUN expression is critical for inhibition of IL-17 production
(22) and the maintenance of suppressive regulatory T-cell
function (23). Additionally, production of FRA1, a member of
the FOS protein family, is increased by B cell stimulation (24).
Furthermore, JUNB modulates the proliferation of B cells (25).
This evidence suggests that FRA1 and JUNB may be involved in
regulating the inflammatory immune response.
We hypothesized that FRA1 and JUNB modulate the
Th17 cell-mediated inflammatory response. The aim of this study
was to elucidate whether FRA1 and JUNB regulate autoimmune
arthritis via Th17 cell differentiation and factors downstream of
STAT3. We used in vitro models, in vivo animal models, and clinical specimens from patients with RA to investigate the biological
importance of this pathway.

Accession Codes

Raw RNA-seq data have been deposited in the NCBI Sequence
Read Archive (SRR6320798 and SRR6320799).
A detailed description of all other experimental procedures and
the statistical analysis is provided in the Section “Supplementary
Materials and Methods” in Data Sheet S1 in Supplementary Material.

RESULTS
STAT3 Target Genes Are Differentially
Expressed in Mouse Th17 Cells

Potential STAT3-binding sites were identified using publicly available chromatin immunoprecipitation sequencing (ChIP-Seq) data
cross-referenced with differentially expressed genes in Th17 cells
(14). We sequenced mRNA obtained from Th17 cells and naïve
T cells and compared the results with potential STAT3-binding
targets identified by ChIP-Seq to identify STAT3-regulated genes
involved in Th17 cell differentiation. The literature was systematically reviewed for downstream STAT3 targets in humans and
mice in multiple biological contexts. By combining these three
datasets, we searched for genes with STAT3-binding sites that
are upregulated during Th17 cell differentiation (Figure 1A;
Table S1 in Supplementary Material). RNA-Seq was performed
to identify genes differentially expressed between Th17 cells and
naïve T cells. This integrated approach suggested that Fosl1 (the
gene locus of Fra1) and Junb are Th17 cell differentiation factors
downstream of STAT3. As shown in Figures 1B–F and Table S2 in
Supplementary Material, Fos and Jun were the predominant AP-1
subtypes expressed in naïve (CD4+CD62L+) T cells, whereas Fosl1
and Junb were the predominant subtypes in Th17 cells. Other AP-1
subtypes were downregulated, suggesting that Fosl1 and Junb
AP-1 subtypes play an important role in Th17 cell differentiation.

Fra1 and Junb Are Highly Expressed in
Th17 Cells, and Their Expression Is
Regulated Directly by STAT3 in Mice

MATERIALS AND METHODS
Mice

Quantitative real-time reverse transcription PCR (qRT-PCR)
and immunoblot analyzes were used to confirm Fra1 and Junb

Collagen-induced arthritis (CIA) was induced in 6–8-week-old
male DBA/1J, BALB/c, and C57BL/6 mice (Orient, Korea).
Frontiers in Immunology | www.frontiersin.org
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Figure 1 | Signal transducer and activator of transcription 3 (STAT3) target genes are differentially expressed in naïve and T helper 17 (Th17) cells. Naïve
T cells (CD4+CD62L+) were isolated from 6-week-old mice (n = 3), stimulated under Th17-polarizing conditions for 3 days, and then sorted for CD4+CD62L−
expression. RNA was sequenced using the Illumina GA IIx. STAT3 chromatin immunoprecipitation sequencing (ChIP-Seq) data for CD4+ T cells were
downloaded from the NCBI Sequence Read Archive (SRP002451). (A) A comparison of differentially expressed genes identified by RNA-Seq, STAT3-binding
target genes identified by ChIP-Seq, and the downstream targets of STAT3. The expression of (B) IL17a and (C–F) activator protein 1 transcription factor target
genes [(C) Fos, (D) Jun, (E) Fosl1, and (F) Junb] was compared between naïve T cells and Th17 cells, with reference to STAT3-binding target genes (obtained
from STAT3 ChIP-Seq data in Th17 cells). The peak profiles are color-coded as follows: naïve T cells (RNA-Seq: blue), Th17 cells (RNA-Seq: red), and
STAT3-binding genes (ChIP-Seq: green).

Th17-polarizing conditions (Figure 3C). STAT3 overexpression
increased the relative levels of Fra1 and Junb mRNA (Figure 3D),
while in vitro treatment with IL-6 upregulated Fra1 and Junb
mRNA (Figure 3E).
Co-immunoprecipitation studies were performed using antiFRA1 and anti-JUNB antibodies followed by immunoblotting
with antibodies against STAT3 to determine whether FRA1 and
JUNB physically interact with STAT3. Both FRA1 and JUNB
were found to form a complex with STAT3 (Figure 3F). We
performed ChIP and qPCR to examine whether STAT3 binds
directly to the promoter regions of Fosl1 and Junb. The ChIPqPCR results were compared with publicly available ChIP-Seq
data from Th17 cells. We found that STAT3 binds to the predicted recognition sites upstream of Fosl1 and Junb, suggesting
that it regulates their expression by binding directly to their
promoters (Figure 3G). Using confocal microscopy, we found
that FRA1 and JUNB were colocalized with phosphorylated
STAT3 in CD4+ splenic T cells and Th17 cells from arthritic mice
(Figures 3H,I). These findings suggest that STAT3 signaling is
critical for the expression and activation of FRA1 and JUNB
during Th17 cell differentiation.

expression. Among the various AP-1 subtypes, only Fra1 and Junb
mRNA levels were significantly increased in Th17 cells compared
with naive T cells (Figures 2A,B). These findings supported
the RNA-Seq results. Immunoblot analysis also showed high
levels of FRA1 and JUNB expression in Th17 cells (Figure 2C).
Co-immunoprecipitation studies were performed using antibodies against Jun family proteins (i.e., JUNB and c-JUN), followed
by immunoblotting using antibodies against FOS family proteins
(i.e., FRA1, c-FOS, and FOSB) to determine whether FRA1 and
JUNB form a heterodimeric AP-1 complex. It was found that FRA1
forms a complex with JUNB, but not with c-JUN (Figure 2D).
Next, we investigated the functional association between the
FRA1–JUNB complex and STAT3. The STAT3 signaling pathway
was inhibited using genetically engineered STAT3-deficient
CD4+ T cells and STA-21, which blocks the DNA-binding
activity of STAT3 (26). As shown in Figure 3A, CD4+ T cells
harboring Stat3fl/flCd4-Cre had markedly decreased levels of
Fra1 and Junb mRNA under both neutral and Th17-polarizing
conditions. Treatment with STA-21 profoundly decreased the
expression of FRA1, JUNB, and STAT3 (Figure 3B). Moreover,
STA-21 decreased the levels of STAT3 phosphorylation under
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Figure 2 | Both Fos-related antigen 1 (FRA1) and JUNB are highly expressed in T helper 17 (Th17) cells. (A,B) Naïve T cells (CD4+CD62L+) were isolated from
6-week-old C57BL/6 mice (n = 3) and cultured for 3 days under the indicated promoters. Relative mRNA levels were measured by qRT-PCR. (C) Protein extracts
were prepared from CD4+ T cells (Tconv) and CD4+ T cells cultured for 3 days under Th17-polarizing conditions (Th17). FRA1 and JUNB protein levels were
evaluated by immunoblotting. (D) CD4+ T cells cultured under Th17-polarizing conditions were lysed, and the cell lysates were subjected to co-immunoprecipitation
with anti-JUNB and anti-c-JUN antibodies and immunoblotting with anti-FRA1, anti-c-FOS, and anti-FOSB antibodies. Data are representative of three (A–C) or two
(D) independent experiments, each performed in triplicate (A,B). The data were analyzed using an unpaired t-test or one-way ANOVA with Bonferroni’s post hoc
test. Error bars show the SEM. *p < 0.05, **p < 0.005, and ***p < 0.0005.

Expression of IL-17 Is Directly Regulated
by the FRA1–JUNB Complex

promoter. The interaction between the FRA1–JUNB complex and
the AP-1-binding motif within the IL17a promoter region was
examined by electrophoretic mobility shift assay. The anti-FRA1
and anti-JUNB antibodies caused a super shift of the labeled
DNA probe, indicating that the AP-1-binding motif interacts
specifically with FRA1 and JUNB (Figure 4G). This finding was
confirmed by an analysis of the IL17a promoter using a luciferase reporter system. Overexpression of both FRA1 and JUNB
increased luciferase activity in EL4 cells. Simultaneous overexpression of FRA1 and JUNB caused luciferase activity to increase
twofold (Figure 4H). Silencing of Fra1 and Junb caused a greater
than twofold reduction in luciferase activity. Simultaneous overexpression of c-FOS and c-JUN caused a significant decrease in
the luciferase activity induced by the IL17a promoter (Figure 4I).
ChIP-qPCR analyses showed that FRA1 and JUNB bind directly
to the IL17a gene loci and to gene loci encoding other Th17 cell
differentiation activators, such as IL21, IL22, and Rorc (Figure 4J).
These findings indicate that the FRA1–JUNB complex binds to

The AP-1 family plays a versatile role in T-cell development (27).
Levels of IL-17 were measured in Fra1- and Junb-overexpressing
and silenced cells. The relative levels of IL17 mRNA were significantly increased in cells overexpressing Fra1 and Junb. The
relative mRNA levels of other genes associated with Th17 cells,
such as IL21, IL22, and Rorc (the RORγt gene locus), were also
increased (Figures 4A,B). CD4+IL-17+ cells and IL17 mRNA
levels were significantly decreased when Fra1 and Junb were
silenced under Th17-polarizing conditions (Figures 4C,D). By
contrast, when c-Fos and c-Jun, the dominant AP-1 subtypes
in naïve T cells, were overexpressed, IL17 mRNA levels were
decreased significantly (Figures 4E,F). These findings support
the specificity of the role of the FRA1–JUNB complex in Th17 cell
differentiation.
We next investigated whether the FRA1–JUNB complex
directly regulates IL-17 expression by binding to the IL17a
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Figure 3 | Signal transducer and activator of transcription 3 (STAT3)-mediated activation of Fos-related antigen 1 (FRA1) and JUNB in T helper 17 (Th17) cells.
(A) CD4+ T cells from Stat3fl/fl and Stat3fl/flCd4-Cre were isolated (left panel) or cultured under Th17-polarizing conditions for 3 days (right panel). (B,C) CD4+ T cells
were pretreated with STA-21 for 1 day, cultured under Th17-polarizing conditions for a further 3 days, and then treated with interleukin (IL)-6 for 2 h (C) before
harvesting and lysing. (D) LBRM cells were transfected with a STAT3 expression vector, and the cells were cultured for 3 weeks in the presence of neomycin
(10 µg/ml). (E) CD4+ T cells were cultured in the presence of IL-6 for 16 h. (F) CD4+ T cells were cultured under Th0- or Th17-polarizing conditions for 3 days and the
lysed. The cell lysates were subjected to immunoprecipitation with an anti-phospho-STAT3Y705 antibody and immunoblotting with anti-phospho-FRA1 or antiphospho-JUNB antibodies. (G) The STAT3-binding region (green) detected by STAT3 chromatin immunoprecipitation (ChIP) sequencing in Th17 cells is shown along
with the Fosl1 and Junb loci, including the primer sites (yellow boxes) (left panel). The negative control cyclophilin showed no enrichment (data not shown). CD4+
T cells were cultured under Th17-polarizing conditions for 3 days. ChIP-qPCR analysis was performed using an anti-STAT3 antibody and primers specific for Fosl1
and Junb (right panel). (H,I) Splenic tissue was collected from collagen-induced arthritis mice. CD4+ splenic T cells and Th17 cells from arthritic mice were stained
for CD4 (white), FRA1, JUNB (green), and phospho-STAT3Y705 (H) or DAPI (I) (blue). Data are representative of three (B–I) and two (A) independent experiments,
each performed in triplicate (A,D,E,G). The data were analyzed using an unpaired t-test; error bars show the SEM. *p < 0.05, **p < 0.005, and ***p < 0.0005.

the joint tissues (Figure 5B). Histological examination showed
that the ankle joints of Fra1/Junb-silenced mice had less inflammation and cartilage damage (Figure 5C). Inhibition of Fra1/Junb
also reduced the expression of Th17 cytokines such as IL-6, IL-17,
IL-1β, and tumor necrosis factor-α in joint tissue. Other mediators
of joint destruction such as vascular endothelial growth factor
and receptor activator of nuclear factor κB ligand (RANKL) were
also downregulated (Figure S1A in Supplementary Material). In
CIA mice, disease severity was correlated with the level of type
II collagen (CII)-specific IgG antibodies (30). Silencing of Fra1
and Junb reduced T-cell proliferation and CII-specific antibody
production (Figures S1B,C in Supplementary Material). It also

the IL17a promoter region, and that this binding activates IL17
gene transcription.

FRA1 and JUNB Are Critical for the
Pathogenesis of CIA

T helper 17 cells and IL-17 contribute significantly to the development of RA (28, 29). To examine the in vivo role of the FRA1–
JUNB complex in rheumatoid inflammation, Fra1 and Junb were
silenced in CIA mice by injecting Fra1 and Junb short hairpin
RNA vectors. This markedly reduced the incidence of arthritis
and decreased the arthritis score (Figure 5A). The numbers of
FRA1+, JUNB+, and IL-17+ cells were significantly lower within
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Figure 4 | Expression of interleukin (IL)-17 is directly mediated by the Fos-related antigen 1 (FRA1)–JUNB complex in T helper 17 (Th17) cells. LBRM cells were
transfected with vectors and cultured for 3 weeks with neomycin (10 µg/ml) (A,B,E,F). (A,B) The relative mRNA levels of each gene were measured by qRT-PCR.
(C,D) CD4+ T cells were infected with lentiviruses harboring constructs designed to knockdown Fra1 and Junb. Cells were then cultured under Th17-polarizing
conditions for 3 days. CD4+IL-17+ T cells were identified by flow cytometry, and relative mRNA levels were measured by qRT-PCR. (E,F) The relative mRNA level of
each gene was measured by qRT-PCR. (G) Nuclear extracts from Th17 cells were analyzed by electrophoretic mobility shift assay incorporating a radiolabeled
probe derived from the activator protein 1-binding site of the IL17a locus and antibodies specific for FRA1 or JUNB. (H,I) EL4 cells were transiently transfected with
expression vectors and IL17a promoter constructs with a CNS2 enhancer region. Luciferase activity was measured using a dual-luciferase reporter assay system.
(J) CD4+ T cells were cultured under Th17-polarizing conditions. Chromatin immunoprecipitation-qPCR was performed using anti-FRA1 or anti-JUNB antibodies
with primers specific for each gene locus. Data are representative of at least three independent experiments, performed in triplicate. Data were analyzed using an
unpaired t-test; error bars show the SEM. *p < 0.05, **p < 0.005, and ***p < 0.0005.

immunoblotting (Figure 5D). The incidence of arthritis and
the arthritis score were significantly increased (Figures 5E,F).
There was a marked increase in the levels of IL-17, FRA1, and
JUNB in the spleen (Figure 5G). The relative mRNA level of the
osteoclastogenic marker tartrate-resistant acid phosphatase was
significantly higher (Figure 5H), while CII-specific T-cell proliferation and IgG production were also increased (Figures 5I–K).
Overexpression of FRA1/JUNB profoundly increased CIA

substantially reduced the population of IL-17-producing CD4+
T cells, considered to be Th17 cells, in the spleen and draining
lymph nodes (Figure S1D in Supplementary Material).
CD4+ T cells in Fra1/Junb Tg mice had different proportions
of Th1 and Th17 cells (Figure S2 in Supplementary Material).
CIA was induced in Fra1/Junb transgenic mice to investigate
the in vivo effects of Fra1 and Junb overexpression. Splenocytes
were examined for HA-tagged FRA1/JUNB transgene by
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Figure 5 | Fos-related antigen 1 (FRA1) and JUNB are involved in the pathogenesis of collagen-induced arthritis, T helper 17 cell differentiation, and rheumatoid
inflammation in mice. Arthritis was induced in mice, and shRNA control or shRNAFra1/shRNAJunb vectors were injected on days 7 and 14 (n = 5–7). (A) Arthritis
severity was measured using the incidence and mean arthritis score. (B) Splenic tissue from each mouse was stained. Positively stained cells were counted visually
by four individuals from high-magnification images projected onto a screen, and the mean values are presented as a histogram. (C) On day 30 after immunization,
tissues were sampled from the ankle joints and stained with toluidine blue, Safranin O (scale bar = 100 µm), H&E [scale bar = 500 µm (left); 100 µm (right)], or
tartrate-resistant acid phosphatase (TRAP) (scale bar = 200 µm). The inflammation and cartilage scores are shown in bar graphs (right panel). (D) Splenocytes were
examined for the HA-tagged FRA1/JUNB transgene by immunoblotting. (E,F) Disease severity was recorded using the incidence and mean arthritis score.
(G) Splenic tissue from each mouse was stained for FRA1, JUNB, and interleukin-17 in CD4+ T cells and examined by laser confocal microscopy. (H) The relative
levels of TRAP mRNA in cells from the ankle joints were measured by qRT-PCR. (I) T-cell proliferation was analyzed using a mixed-lymphocyte reaction. (J,K) The
levels of IgG1 and IgG2a antibodies specific to type II collagen were measured in serum. Data are representative of more than two independent experiments. Data
were analyzed using an unpaired t-test or two-way ANOVA with Bonferroni’s post hoc test; error bars show the SEM. *p < 0.05, **p < 0.005, and ***p < 0.0005.

joint pathology (Figure S3A in Supplementary Material).
Immunostaining showed that the expression of various proinflammatory cytokines and RANKL, a mediator of osteoclastogenesis,
Frontiers in Immunology | www.frontiersin.org

was significantly greater in the joint tissues of transgenic mice
with CIA (Figure S3B in Supplementary Material). IL-17 mRNA
levels and Th17 cell numbers were increased markedly (Figures
7
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Fra1 was silenced in CD4+ T cells isolated from SFMCs of RA
patients, IL-17 secretion was decreased during Th17 polarization (Figure 6E). The expression of both FRA1 and JUNB was
particularly high in the inflamed synovium of RA patients, a
region enriched with inflammatory immune cells (Figure 6F). Of
note, FRA1, JUNB, and phosphorylated STAT3 were colocalized
in the inflamed synovium, which further supported our in vitro
experimental results. A schematic illustration of the inflammatory signaling pathway induced by FRA1/JUNB is shown in
Figure 6G. Th17 conditioning induces an inflammatory signal
by promoting FRA1/JUNB. The inflammatory response is mediated by activation of STAT3, which regulates genes involved in
Th17 cell differentiation. This cascade induces excessive inflammation and autoimmunity resulting in RA.

S3C,D in Supplementary Material). These findings suggest that
the FRA1–JUNB complex plays a major role in the development
of CIA, likely through the induction of Th17 cell differentiation.

Expression and Potential Functions of
FRA1 and JUNB in RA Patients

We demonstrated in vivo roles of FRA1 and JUNB in mice with
CIA, an animal disease model for RA. To confirm the roles of
FRA1 and JUNB in patients with RA, FRA1 was overexpressed in
CD4+ T cells isolated from healthy controls. FRA1 overexpression
increased the proportion of IL-17-producing CD4+ T cells during
Th17 polarization (Figure 6A). These cells produced significantly
higher levels of IL17a mRNA and cytokines (Figure 6B). Fra1
silencing decreased IL17a mRNA levels and IL-17 secretion
(Figure 6C). There were significantly increased the transcription
levels of Fra1 and Junb among peripheral blood mononuclear
cells (PBMCs) and synovial fluid mononuclear cells (SFMCs)
from RA patients compared with PBMCs from healthy controls
(Figure 6D). Junb was also upregulated in RA patients. When

DISCUSSION
Although FRA1 and JUNB may have modulatory activity in the
immune inflammatory response (18, 19), there is currently no

Figure 6 | Expression and potential function of Fos-related antigen 1 (FRA1) and JUNB in rheumatoid arthritis (RA) patients. (A,B) Flow cytometry, qRT-PCR, and
ELISA. CD4+ T cells were isolated from healthy peripheral blood mononuclear cells (PBMCs) and infected with retroviruses containing FRA1 on day 1. The infected
cells were then cultured under T helper 17 (Th17)-polarizing conditions for 3 days and analyzed. (C) qRT-PCR and ELISA. CD4+ T cells from healthy controls were
infected with lentiviruses harboring constructs designed to knockdown Fra1. Cells were then cultured under Th17-polarizing conditions for 3 days. (D) qRT-PCR
analysis. Total RNA was extracted from PBMCs isolated from healthy controls and from PBMCs and synovial fluid mononuclear cells (SFMCs) from RA patients.
(E) ELISA. CD4+ T cells in SFMCs from RA patients were infected with lentiviruses harboring constructs designed to knockdown Fra1. Cells were then cultured
under Th17-polarizing conditions for 3 days. (F) Synovial tissue obtained from RA patients. Sections were immunostained. Data are representative of three
(A–C,F) and two (D,E) independent experiments, each performed in triplicate. (G) A schematic illustration of the inflammatory signaling pathway mediated by FRA1/
JUNB. (B–E) Data are representative of more than three independent experiments. Data were analyzed using an unpaired t-test; error bars show the SEM.
*p < 0.05, **p < 0.005, and ***p < 0.0005.

Frontiers in Immunology | www.frontiersin.org

8

December 2017 | Volume 8 | Article 1793

Moon et al.

FRA-1/JUNB Induce Th17 and Arthritis

evidence in the literature to support this notion in autoimmune
disorders mediated by STAT3 and Th17 cells. In this study, we
found evidence of previously unidentified functions of FRA1 and
JUNB in Th17 cell differentiation and autoimmune disease. We
investigated the modulatory function and underlying mechanisms of FRA1 and JUNB in a murine model of inflammatory
arthritis. The predominant conclusion from this study was that
FRA1 and JUNB exacerbate inflammation via the induction of
Th17 cells. To our knowledge, this is the first study to implicate
FRA1 and JUNB directly in STAT3 activation and regulation of
Th17 cell proliferation. These observations suggest a previously
unidentified function of these factors in autoimmune disease.
Activator protein 1 is comprised of dimers of FOS and JUN
protein family members (31, 32). The diverse functions of AP-1
family members result from heterodimer formation between the
FOS and JUN proteins (33). AP-1 is also involved in cell functions including proliferation, differentiation, and apoptosis. For
example, the FRA2–JUND complex is involved in the terminal
differentiation of granulosa cells into luteal cells (34) and T-cell
activation (35). Additionally, AP-1 factors may play important
roles in autoimmune disease and Th17 cell differentiation. It was
suggested that basic leucine zipper transcription factor, ATF-like
(BATF), an AP-1 protein, leads to increased Th17 cell differentiation, whereas BATF deficiency results in IL-17 downregulation
(12). Loss of the AP-1 family member Fosl2 in T cells improved
EAE severity via suppression of Th17 cell plasticity (36). We
performed an integrative analysis using RNA-Seq and ChIP-Seq
data to identify key factors downstream of STAT3 involved in
Th17 cell differentiation. This integrative analysis suggested that
upregulation of Fra1 and Junb drives and promotes Th17 cell
differentiation.
Signal transducer and activator of transcription 3-mediated
IL-17 expression and Th17 cell differentiation involve AP-1
family proteins. Previous studies have shown a biological link
between the STAT3 signaling pathway and the AP-1 family of
transcription factors (12, 37, 38). In particular, STAT3-mediated
expression of BATF, an AP-1 subfamily member, is associated
with Th17 cell differentiation (12). In this study, RNA-Seq analysis
showed that the expression of cFos and cJun was higher in naïve
T cells. This suggests that AP-1 subtype switching from c-FOS–
c-JUN to FRA1/JUNB is essential for Th17 cell differentiation. It
can also be postulated that activation of c-FOS–c-JUN must be
suppressed in parallel with activation of FRA1/JUNB by STAT3
during polarization toward the Th17 subtype. The present study
identified an AP-1 complex comprising FRA1 and JUNB, which
appears to function as a key factor downstream of STAT3 in
Th17 cell differentiation. It appears that AP-1 subtype switching,
particularly from c-FOS, FOSB, and c-JUN to FRA1 and JUNB, is
required for STAT3-mediated Th17 cell differentiation.
The AP-1 family includes the c-JUN and c-FOS proteins, which
play important roles in IL-17 expression and Th17 cell functions.
It has been demonstrated that BATF binds to intergenic components in the IL17a locus and to IL17 promoters, both of which are
essential for Th17 differentiation (12). Additionally, the BATF–
JUNB and BATF–JUND complexes have been shown to cooperate with IRF4 in Th17 cells to promote transcription of IL17 (39).
The c-JUN transcription factor that heterodimerizes with c-FOS
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to generate the AP-1 transcription factor complex is involved
in suppression of IL-17 production in developing Th17 cells
(16, 22). FRA2 is also a negative regulator of IL-17 (36). We
observed that overexpression of FRA2 decreased the expression
of IL17a in a promoter-fused luciferase reporter assay (data not
shown). We also found that expression levels of c-Fos and c-Jun
were significantly reduced, whereas Batf expression was increased
in Th17 cells compared with naïve T cells. Overexpression of c-Fos
and c-Jun significantly decreased IL17 mRNA levels. The FRA1–
JUNB complex directly activates expression of IL-17, a cytokine
produced by Th17 cells. This complex plays a role in promoting
the expression of other cytokines associated with Th17 cells, such
as IL-21 and IL-22, by directly binding to their promoter regions.
These results suggest that FRA1 and JUNB are involved in IL-17
production and Th17 cell differentiation.
Although FRA1/JUNB and c-FOS/c-JUN compete for the
same AP-1-binding sites within the IL17a promoter, we found
in this study that IL17a promoter activity was increased by FRA1
and JUNB overexpression but decreased by c-FOS and c-JUN
overexpression. We observed an interaction between p-STAT3
and p-FRA1 or p-JUNB in Th17 cells; therefore, FRA1/JUNB
and c-FOS/c-JUN may be involved in AP-1 subtype switching.
Additionally, p-FRA1 binds to p-JUNB in Th17 cells. Further
study is needed to confirm the AP-1 subtype switching factors
involved and the mechanism of interaction between p-FRA1 and
p-JUNB in Th17 cells.
This study has certain limitations. One is that the animal
studies were conducted using FRA1/JUNB-1 overexpression
and knockdown vectors. Adoptive transfer studies in conditional
overexpression and knockout mice are required to confirm that
FRA1/JUNB-1 regulates CD4+ T cells, leading to autoimmune
arthritis. Nonetheless, this study is the first to demonstrate functions of FRA1/JUNB-1 in Th17 cell differentiation and autoimmune arthritis. Future studies using adoptive transfer models
with CD4+ T cells differentially expressing FRA1/JUNB-1 are
required to validate our data more precisely.
Uncontrolled Th17 cell activation is responsible for the onset
of several autoimmune diseases. Th17 cells cause tissue injury via
production of IL-17, as observed in CIA mouse models of disease.
The present study showed that the FRA1–JUNB complex plays a
central role in the development of RA, which is a Th17-mediated
autoimmune disease. The FRA1–JUNB complex may be clinically relevant as it functions as a Th17 cell-specific regulator of
proinflammatory cytokine production in CIA mouse models
and hence RA. In the RA mouse model used in this study, FRA1/
JUNB overexpression resulted in the development of severe
inflammatory symptoms and augmented expression of IL-17 in
mice. Notably, this has fueled interest in the genetic importance
of FRA1/JUNB in human RA in the context of promoted STAT3
activity. FRA1 overexpression activated Th17 cell differentiation
in PBMCs from healthy controls; however, FRA1 silencing downregulated IL-17 production in SFMCs from RA patients. This may
indicate the potential of the FRA1–JUNB complex as a therapeutic target in human autoimmune disease. In conclusion, our
results suggest a previously unidentified function of FRA1/JUNB
in T-cell-mediated autoimmune diseases. FRA1/JUNB directly
modulates STAT3 activation and Th17 cell differentiation. Our
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identification of the involvement of FRA1/JUNB in T-cell deve
lopment provides a potential therapeutic target for the treatment
of autoimmune diseases.
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